167 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
22 May 24
2024 Annual General Meeting of Shareholders
4:15pm
a majority of the voting power represented and voting on such proposal in person or by proxy on the matter presented for passage.
The approval … of Proposals 2, 4, 5 and 7 is subject to the affirmative vote of the holders of a majority of the voting power represented and voting on such proposal in person
POS AM
CANF
Can-Fite Biopharma Ltd
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
, replacement or suspension of our Amended and Restated Articles of Association regarding the election of directors, as described above, require a majority … from the count of the voting power present and voting, provided that such majority constitutes more than 20% of our then issued and outstanding share
F-3/A
dlaph4
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
F-3
z188 4g1lwzqj
12 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-10.1
r4fjrz4g48 d75lk8081
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-10.2
3iyffyy621iv9t
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-10.3
7tzbbd72t qxxbpp
22 Nov 23
Report of Foreign Private Issuer
4:15pm
POS AM
mcttwe
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm
F-3
95rdf
1 Sep 23
Shelf registration (foreign)
4:15pm
6-K
zso21gd5wjd gymh9di8
7 Aug 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.1
t0rm3nfiw2qhkdbi
23 Jun 23
2023 Annual General Meeting of Shareholders
4:15pm
POS AM
jgn9tzr0
21 Apr 23
Prospectus update (post-effective amendment)
4:16pm
POS AM
g1hi8mh uhq85bx3g7c3
31 Mar 23
Prospectus update (post-effective amendment)
4:30pm
6-K
doc83794c udj
7 Sep 22
Report of Foreign Private Issuer
4:30pm